Shares of CBRS, the AI infrastructure company known for its pioneering wafer-scale processor technology, tumbled 7.05% in Thursday's trading session to $204.50, surrendering a substantial portion of the prior day's advance. The drop followed a closing price of $220.00 on Wednesday, when the stock rallied nearly 5% on news of a technical partnership with AMD. Cerebras Systems, which went public in May 2026 at $185 per share, has experienced extreme volatility since its IPO, trading as high as $386.34 on its first day before falling below $161 in late June. Thursday's selloff reflects a combination of profit-taking after a sharp multi-day rally and renewed scrutiny of the company's near-term profitability trajectory.
The most immediate driver behind Thursday's decline is straightforward: traders who rode the stock higher during its blistering ~27% surge from $172.86 on July 17 to $220.00 on July 23 are cashing out. That rally was fueled by two high-profile partnership announcements in rapid succession — first with CRWD on July 22, in which CrowdStrike agreed to use Cerebras' inference infrastructure to power its Falcon AI Detection and Response product, and then with AMD on July 23, unveiled at AMD's Advancing AI 2026 conference, integrating Cerebras' Wafer-Scale Engine into AMD's Helios rackscale systems.
The pattern of partnership-driven spikes quickly fading is not new for CBRS. Following the CrowdStrike announcement on July 22, the stock surged as much as 18% intraday to $244 before closing at $209.80, surrendering more than half those gains in a single session. Thursday's pullback extends that "buy the rumor, sell the news" dynamic, as the market digests that while these partnerships validate Cerebras' technology, neither came with disclosed revenue figures, contract sizes, or exclusivity terms that would materially alter near-term financials.
Beneath the headline-driven volatility, fundamental worries about Cerebras' profitability path continue to weigh on investor sentiment. In its first quarterly report as a public company, CBRS delivered impressive top-line growth — revenue surged 94% year-over-year to $193.4 million — but management's gross margin guidance spooked the market. The company guided for Q2 adjusted gross margin of 36% to 38%, a sharp sequential decline from 47% in Q1, and full-year 2026 gross margin of just 38% to 41%.
The compression stems from Cerebras' aggressive infrastructure buildout to service its landmark agreement with OpenAI, valued at more than $20 billion for 750 megawatts of AI inference capacity. Management disclosed it is temporarily renting back systems from existing customers to accelerate cloud capacity deployment, a stopgap that inflates near-term costs. While the company expects margins to recover once its own data centers come online — with new facilities anticipated in the second half of 2026 — the timeline remains uncertain, and investors are increasingly demanding proof of execution rather than promises.
Thursday's selloff in CBRS also unfolded against a backdrop of cooling enthusiasm across the AI semiconductor space. The market is transitioning from a phase where any AI-related headline attracted aggressive buying to one where investors are demanding concrete earnings delivery relative to elevated valuations. Reports of jitters over GOOG / GOOGL AI spending plans and broader questions about the return on massive infrastructure investments have created headwinds for the entire sector. With CBRS trading at a lofty price-to-sales multiple and still reporting GAAP losses, it remains particularly vulnerable when risk appetite contracts.
Thursday's decline came with elevated trading volume, consistent with the pattern of heightened turnover that has characterized CBRS shares since the IPO. The stock's average daily volume over the past several weeks has run well above typical levels for a mid-cap semiconductor name, reflecting the intense speculative interest in the AI infrastructure theme. The move lower pushed the stock back below the $210 level, which had acted as resistance during the July 21 session before being broken. The stock remains more than 43% below its all-time high of $386.34 and roughly 10% above its late-June trough near $161.
Looking ahead, the next major catalyst for CBRS will be its second-quarter earnings report, which Robinhood indicates is expected around August 12. Investors will be laser-focused on gross margin trajectory, any revisions to the full-year outlook, and concrete updates on data center capacity expansion and AWS deployment progress. Additionally, the looming insider lock-up expiration — which features unconventional early-unlock clauses triggered if market capitalization exceeds $40 billion — represents a potential overhang. On the positive side, the company's approximately $25 billion in remaining performance obligations provides exceptional revenue visibility, and 11 analysts tracked by S&P Global maintain a consensus "Strong Buy" rating with an average price target of $291.09. Whether CBRS can convert its partnership momentum and massive backlog into sustained shareholder returns remains the central question.
For traders seeking a data-driven edge in navigating volatile names like CBRS, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to evolving market conditions. Tickeron provides hundreds of automated trading bots spanning thousands of tickers across different strategies, timeframes, and performance metrics. Only the strongest performers under current market conditions are featured in the Trending AI Robots section, giving traders a dynamic window into which algorithms are successfully reading today's market. Bots vary by approach — from swing trading to trend following — and each is transparent about its historical performance and traded symbols. Visit the Trending AI Robots page to explore which strategies are currently outperforming.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 1 of 1 cases where CBRS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CBRS as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CBRS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 1 similar instances when the indicator turned negative. In 1 of the 1 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.120) is normal, around the industry mean (5.869). P/E Ratio (-17.552) is within average values for comparable stocks, (16.161). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors